ARCH Venture Management, LLC — 13F Holdings & Portfolio

CIK 1274403 · latest 13F-HR filed 2026-08-14

ARCH Venture Management, LLC manages $1.10B in 13F-reported U.S. long-equity assets across 12 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PBLS (15.95%), BEAM (14.16%), RAPP (14.12%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions and exited 1; 6 existing positions rose in reported value and 2 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$1.10B

Long-equity book

Holdings
12

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+3 / −1 / ↑6 / ↓2

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 99.3%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 30, 2026.

Address
8755 WEST HIGGINS ROAD
SUITE 1025
CHICAGO, IL 60631-2176
Phone
(773) 380-6600
Name Title / Status Ownership Type
BUROW, KRISTINA, MARIE ControlMANAGING DIRECTOR, VICE PRESIDENT, AND SHAREHOLDER
since Sep 2020
10–25%Individual
Berns, Paul, Louis ControlMANAGING DIRECTOR
since Jan 2024
Less than 5%Individual
CRANDELL, KEITH, LAWRENCE ControlMANAGING DIRECTOR, PRESIDENT, SECRETARY AND SHAREHOLDER
since Jun 2001
25–50%Individual
NELSEN, ROBERT, TAYLOR ControlMANAGING DIRECTOR, CEO, AND SHAREHOLDER
since Jun 2001
25–50%Individual
BYBEE, CLINTON, WHITEWOODMANAGING DIRECTOR
since Sep 2020
Less than 5%Individual
GILLIS, STEVEN, NMNMANAGING DIRECTOR
since Oct 2007
Less than 5%Individual
MCDONNELL, MARK, ANDREWMANAGING DIRECTOR, CFO AND CAO
since Nov 2011
Less than 5%Individual
Ownership & leadership changes · 4 filings with changes since Mar 30, 2012

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 28, 2025 filing
  • AddedBerns, Paul, Louis · MANAGING DIRECTOR · Less than 5% · control person
Mar 26, 2021 filing
  • No longer listedTHURK, PAUL, STEVEN · MANAGING DIRECTOR · Less than 5% · listed since Nov 2011
Nov 2, 2020 filing
  • ChangedBUROW, KRISTINA, MARIE · title MANAGING DIRECTOR → MANAGING DIRECTOR, VICE PRESIDENT, AND SHAREHOLDER; ownership Less than 5% → 10–25%; now a control person
  • ChangedBYBEE, CLINTON, WHITEWOOD · title MANAGING DIRECTOR AND SHAREHOLDER → MANAGING DIRECTOR; ownership 25–50% → Less than 5%; no longer a control person
  • ChangedCRANDELL, KEITH, LAWRENCE · title MANAGING DIRECTOR, PRESIDENT AND SHAREHOLDER → MANAGING DIRECTOR, PRESIDENT, SECRETARY AND SHAREHOLDER
  • ChangedNELSEN, ROBERT, TAYLOR · title MANAGING DIRECTOR, VICE PRESIDENT, SECRETARY AND SHAREHOLDER → MANAGING DIRECTOR, CEO, AND SHAREHOLDER
Dec 4, 2018 filing
  • No longer listedLAZARUS, STEVEN, NMN · MANAGING DIRECTOR, PRESIDENT, TREASURER AND SHAREHOLDER · 25–50% · control person · listed since Jun 2001
  • ChangedCRANDELL, KEITH, LAWRENCE · title MANAGING DIRECTOR, VICE PRESIDENT, SECRETARY AND SHAREHOLDER → MANAGING DIRECTOR, PRESIDENT AND SHAREHOLDER
  • ChangedNELSEN, ROBERT, TAYLOR · title MANAGING DIRECTOR, ASSISTANT SECRETARY AND SHAREHOLDER → MANAGING DIRECTOR, VICE PRESIDENT, SECRETARY AND SHAREHOLDER
Mar 30, 2012 filing (earliest on record)
  • ListedBUROW, KRISTINA, MARIE · MANAGING DIRECTOR · Less than 5%
  • ListedBYBEE, CLINTON, WHITEWOOD · MANAGING DIRECTOR AND SHAREHOLDER · 25–50% · control person
  • ListedCRANDELL, KEITH, LAWRENCE · MANAGING DIRECTOR, VICE PRESIDENT, SECRETARY AND SHAREHOLDER · 25–50% · control person
  • ListedGILLIS, STEVEN, NMN · MANAGING DIRECTOR · Less than 5%
  • ListedLAZARUS, STEVEN, NMN · MANAGING DIRECTOR, PRESIDENT, TREASURER AND SHAREHOLDER · 25–50% · control person
  • ListedMCDONNELL, MARK, ANDREW · MANAGING DIRECTOR, CFO AND CAO · Less than 5%
  • ListedNELSEN, ROBERT, TAYLOR · MANAGING DIRECTOR, ASSISTANT SECRETARY AND SHAREHOLDER · 25–50% · control person
  • ListedTHURK, PAUL, STEVEN · MANAGING DIRECTOR · Less than 5%

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 6 →

Top Trims

Show all 2 →

Exited Positions

Show all 1 →

ARCH Venture Management, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 PARABILIS MEDICINES INC PBLS 698955101 $175.5M 15.95% 6,412,780 SH
2 BEAM THERAPEUTICS INC BEAM 07373V105 $155.8M 14.16% 4,540,132 SH
3 RAPPORT THERAPEUTICS INC RAPP 75383L102 $155.4M 14.12% 3,728,738 SH
4 SEAPORT THERAPEUTICS INC SPTX 81221K108 $136.6M 12.42% 6,294,951 SH
5 ERASCA INC ERAS 29479A108 $129.9M 11.81% 7,091,557 SH
6 VIR BIOTECHNOLOGY INC VIR 92764N102 $129.4M 11.76% 12,694,163 SH
7 MAZE THERAPEUTICS INC MAZE 578784100 $123.0M 11.18% 4,120,053 SH
8 LYELL IMMUNOPHARMA INC LYEL 55083R203 $45.5M 4.14% 3,247,162 SH
9 GENERATE BIOMEDICINES INC GENB 370920100 $32.8M 2.98% 1,944,426 SH
10 10X GENOMICS INC TXG 88025U109 $8.4M 0.76% 217,834 SH
11 BOUNDLESS BIO INC BOLD 10170A100 $6.7M 0.61% 2,694,095 SH
12 GOSSAMER BIO INC GOSS 38341P102 $1.3M 0.12% 8,055,916 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.10B 12 0001012975-26-000794
2026-03-31 2026-05-15 $677.1M 10 0001012975-26-000461
2025-12-31 2026-02-17 $651.7M 9 0001012975-26-000153
2025-09-30 2025-11-14 $492.4M 9 0001012975-25-000787
Filer Information
Address
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO, IL 60631
Phone
(773) 380-6600
Filing Manager
ARCH Venture Management, LLC
CHICAGO, IL
Signatory
Mark McDonnell
Managing Director, CFO and CAO